Robert M. Arusell

Medicine · Health Sciences

15h-index3.3kcitations30works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(25), Brain Metastases and Treatment(11), Cancer-related cognitive impairment studies(6), Cancer Treatment and Pharmacology(4), Radiomics and Machine Learning in Medical Imaging(4)

Publications30 total

Supplementary Tables 1-3 from A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2023Open Access
Data from A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2023Open Access
Data from A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2023Open Access
Supplementary Tables 1-3 from A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2023Open Access
Double‐blind, randomized phase 3 trial of low‐dose 13‐cis retinoic acid in the prevention of second primaries in head and neck cancer: Long‐term follow‐up of a trial of the Eastern Cooperative Oncology Group‐ACRIN Cancer Research Group (C0590)
Cancer·2017· 28 citedOpen Access
Double blind phase III trial of effects of low dose 13-cisretinoic acid on prevention of second primaries in stages I-II head and neck cancer: A trial of the ECOG-ACRIN Cancer Research Group (C0590).
Journal of Clinical Oncology·2016
Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51
International Journal of Radiation Oncology*Biology*Physics·2011· 136 cited
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
Journal of Neuro-Oncology·2010· 8 citedOpen Access
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
Journal of Clinical Oncology·2008· 274 citedOpen Access
A phase II trial (N0177) of erlotinib and temozolomide (TMZ) combined with radiation therapy (RT) in glioblastoma multiforme (GBM)
Journal of Clinical Oncology·2008· 13 cited
A Prospective Study of Quality of Life in Adults With Newly Diagnosed High-Grade Gliomas
American Journal of Clinical Oncology·2008· 77 cited
A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
Cancer Research·2006· 755 citedOpen Access
Diagnostic and prognostic significance of a t(1;19)(q10;p10) in patients (pts) with low-grade oligodendroglioma and astrocytoma: NCCTG 94–72–53
Journal of Clinical Oncology·2006
Phase II trial of irinotecan (CPT-11) and radiation followed by irinotecan and BCNU in glioblastoma patients (pts)
Journal of Clinical Oncology·2006
Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas
Journal of Neuro-Oncology·2005· 188 cited
A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival
Neurosurgery·2005· 208 cited
Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study
International Journal of Radiation Oncology*Biology*Physics·2005· 160 cited
NCCTG 94–72-53: Diagnostic and prognostic significance of 1p and 19q deletions in patients (pts) with low-grade oligodendroglioma and astrocytoma
Journal of Clinical Oncology·2005· 6 cited
Prospective NCCTG quality of life (QOL) study in adult newly diagnosed high-grade gliomas (HGG)
Journal of Clinical Oncology·2004
Prospective NCCTG quality of life (QOL) study in adult newly diagnosed high-grade gliomas (HGG)
Journal of Clinical Oncology·2004
page 1 of 2Next →

Frequent Co-authors

Jan C. Buckner(25), Paul D. Brown(23), Karla V. Ballman(16), Edward G. Shaw(15), Caterina Giannini(10), Hilary Blair(7), Sandra Passe(7), Robert P. Dinapoli(7), Sara J. Felten(6), Judith R. OʼFallon(6), Walter J. Curran(6), Ross A. Abrams(6), Robert B. Jenkins(5), Mark E. Law(5), Brian Patrick O’Neill(5), Bernd W. Scheithauer(5), Nancy Iturria(5), Cerise A. Brown(5), Teresa A. Rummans(5), Matthew M. Clark(5)